Maple Leaf Foods Reports Results for the Fourth Quarter 2015

MISSISSAUGA, ON, March 1, 2016 /CNW/ - Maple Leaf Foods Inc. (TSX: MFI) today reported its financial results for the fourth quarter and full year ended December 31, 2015.  

  • Adjusted EBITDA(1)(2) margin increased to 8.7% in the fourth quarter, compared to 1.5% last year and 7.1% in the third quarter of 2015
  • Delivered Adjusted Earnings per Share(2)(3) of $0.25 in the quarter compared to a loss of $0.08 in the same quarter last year; and $0.58 for the year compared to a loss of $0.56 last year
  • Net earnings from continuing operations in the quarter of $33.3 million and $41.6 million for the year, compared to net losses of $23.0 million and $213.8 million, respectively in the same periods last year
  • Announced an increase to the regular quarterly dividend to $0.09 per share, effective in the first quarter of 2016

 

"We are very pleased with our consistent earnings growth in the year and fourth quarter, driven by our commercial performance and continued progress lowering operating costs in our new plant network," said Michael H. McCain, President and CEO. "We are entering 2016 with momentum, confident that the strategic goals of our transformational investments have been met, with only normal ramp-up inefficiencies in a single facility remaining. Additionally, Maple Leaf is now a North American leader in the evolution of sustainability in our industry and sustainable protein production, which will underpin our growth well into the future. This, combined with a strong balance sheet, exciting innovation and brand leadership, gives us great cause for optimism in the years ahead."

Consolidated Financial Overview

Fourth Quarter 2015

  • Sales from continuing operations increased 10.0% from last year, or 7.0% after adjusting for the impact of foreign exchange, to $873.1 million, due to higher sales in the Meat Products Group and an additional week in 2015
  • Adjusted Operating Earnings(2)(4) increased to $47.8 million compared to a loss of $13.7 million last year
  • The primary drivers of earnings growth were strong commercial performance across all of the Meat Products Group businesses and increased efficiencies in the Company's new prepared meats plant network
  • The aggregate effect of protein markets was neutral to earnings in the quarter versus long term averages, but positive to last year
  • Adjusted EBITDA margin increased to 8.7% from 1.5% last year and 7.1% in the third quarter of 2015
  • Adjusted Earnings per Share was $0.25 compared to a loss of $0.08 last year
  • Net earnings from continuing operations was $33.3 million ($0.24 per share(5)) compared to a loss of $23.0 million (loss of $0.16 per share) last year due primarily to improved margins in the Meat Products Group
  • Free Cash Flow(6) was $39.1 million compared to a use of $19.7 million last year

 

Full Year 2015

  • Sales from continuing operations increased 4.3% from last year, or 2.4% after adjusting for the impact of foreign exchange, to $3,292.9 million, due to higher sales in the Meat Products Group and an additional week in 2015
  • Adjusted Operating Earnings increased to $109.8 million compared to a loss of $75.5 million last year due to improved margins in the Meat Products Group
  • Adjusted EBITDA margin increased to 6.7% from 0.5% last year
  • Adjusted Earnings per Share was $0.58 compared to a loss of $0.56 last year
  • Net earnings from continuing operations was $41.6 million ($0.30 per share) compared to a loss of $213.8 million (loss of $1.51 per share) last year due primarily to improved margins in the Meat Products Group, non-recurring financing costs that were incurred last year in relation to the repayment of the Company's outstanding debt and lower restructuring and other related costs
  • Free Cash Flow was $11.7 million compared to a use of $621.4 million last year
  • The Company largely completed its prepared meats network strategy, closing the two remaining legacy facilities in the first half of 2015 and reducing a majority of the ramp-up inefficiencies in its new scale facilities

 

Several items are excluded from the discussions of underlying earnings performance as they are not representative of ongoing operational activities. Refer to the section entitled Reconciliation of Non-IFRS Financial Measures at the end of this news release for a description and reconciliation of all non-IFRS financial measures.

Business Segment Review

Following is a summary of sales by business segment:


Three months ended
December 31,

Twelve months ended
December 31,


(Unaudited)

(Audited)

($ thousands)

2015

2014

2015

2014

Meat Products Group


$

868,542



$

789,725



$

3,276,994



$

3,135,376


Agribusiness Group


4,581



4,282



15,938



21,865


Total Sales(2)


$

873,123



$

794,007



$

3,292,932



$

3,157,241


 

The following table summarizes Adjusted Operating Earnings by business segment:

 


Three months ended
December 31,

Twelve months ended
December 31,


(Unaudited)

(Audited)

($ thousands)

2015

2014

2015

2014

Meat Products Group


$

54,619


$

(19,069)


$

108,440


$

(80,381)

Agribusiness Group


(6,862)


5,390


1,360


8,642

Protein Group


$

47,757


$

(13,679)


$

109,800


$

(71,739)

Non-Allocated Costs in Adjusted Operating Earnings(7)





(3,748)

Adjusted Operating Earnings(2)


$

47,757


$

(13,679)


$

109,800


$

(75,487)

 

Meat Products Group

Includes value-added prepared meats, lunch kits and snacks, and fresh pork and poultry products sold under leading Canadian brands such as Maple Leaf®, Schneiders® and many leading regional brands.

Fourth Quarter 2015

Sales of $868.5 million for the fourth quarter increased 10.0% from last year, or 7.0% after adjusting for the impacts of foreign exchange. This improvement was due to increased volume in fresh pork and poultry, a favourable sales mix in fresh poultry and an extra week in the fourth quarter of 2015, which was partially offset by lower selling prices for fresh pork and a slight decline in prepared meats volume. 

Adjusted Operating Earnings for the fourth quarter was $54.6 million compared to a loss of $19.1 million last year. Earnings in prepared meats increased as a result of lower operating costs in the Company's new prepared meats plant network, improved sales mix resulting from a higher proportion of retail branded volume, and pricing. This was partially offset by a sharp rise in pork belly prices, which compressed margins. Fresh pork earnings grew due to increased volume and improved export margins. While industry pork processing margins strengthened compared to last year, when they were below the five year average, the benefit to the Company was partially offset by declining by-product values and a sharp rise in belly prices, which affected prepared meats margins. Earnings in fresh poultry increased due to higher volume, stronger industry processing margins, an improved sales mix reflecting higher retail branded volume and increased operating efficiencies.

Full Year 2015

Sales in the Meat Products Group for 2015 increased 4.5% to $3,277.0 million, or 2.6% after adjusting for the weaker Canadian dollar. Higher sales resulted from increased volume in fresh pork and poultry, pricing in prepared meats that was implemented in the second quarter of 2014, a favourable sales mix in fresh poultry and an extra week in the fourth quarter of 2015. This increase was partially offset by lower selling prices for fresh pork and a slight decline in prepared meats volume.

Adjusted Operating Earnings for 2015 increased to $108.4 million compared to a loss of $80.4 million last year. Earnings in prepared meats benefited from pricing, an improved sales mix, lower overall raw material costs and lower operating costs in the new prepared meats plant network. The Company benefited from the flow through of pricing implemented in the second quarter of 2014 to offset the impact of higher raw material costs driven by the outbreak of the PED virus in U.S. hog production herds. Although on average raw material costs returned to more normalized levels, this decrease was largely offset by the impact of a lower Canadian dollar on the Company's prepared meats business. Lower operating costs resulted primarily from a reduction of duplicative overhead costs, as the Company closed its two remaining legacy plants in the first half of 2015, eliminating the final components of its duplicative supply chain. In addition, during the second half of 2015 the Company continued to make progress in reducing ramp-up inefficiencies in its plant network, primarily at the new prepared meats facility in Hamilton, Ontario.

Fresh pork earnings increased largely as a result of increased volume and improved Canadian retail and export margins. Industry pork processing margins improved significantly over the same period last year, when they were below the five year average, however the benefit of higher prices was partially offset by declining by-product values. Fresh poultry earnings increased as a result of higher volume, improved poultry processing margins, an improved sales mix resulting from increased retail branded volume and increased operating efficiencies.

Agribusiness Group

Includes Canadian hog production operations that primarily supply the Meat Products Group with livestock as well as toll feed sales.

Fourth Quarter 2015

Agribusiness Group sales in the fourth quarter increased to $4.6 million from $4.3 million last year as a result of higher prices for toll feed and an extra week in the fourth quarter of 2015.

Adjusted Operating Earnings declined to a loss of $6.9 million from earnings of $5.4 million last year due to a substantial decline in hog prices, which was not fully offset by the Company's risk management program and the benefit of a lower Canadian dollar.

Full Year 2015

Agribusiness Group sales in 2015 were $15.9 million compared to $21.9 million last year, due to lower external sales volume for feed.  

Adjusted Operating Earnings in 2015 decreased to $1.4 million from $8.6 million last year, as a result of a substantial decline in hog prices in the second half of 2015, which was not fully offset by the Company's risk management program and the benefit of a lower Canadian dollar. Also negatively impacting earnings was an increase in feed grain prices as a result of the weaker Canadian dollar. Increased operating costs were incurred in relation to the ongoing conversion of existing sow barns to loose housing, supporting the Company's animal care program. This was offset by lower costs relating to the prevention of the PED virus.

Other Matters

On February 29, 2016, the Board of Directors approved an increase in the quarterly cash dividend to $0.09 per share, $0.36 per share on an annual basis, from $0.08 per share, payable March 31, 2016, to shareholders of record at the close of business on March 11, 2016. Unless indicated otherwise by the Company in writing at or before the time the dividend is paid, the dividend will be considered an Eligible Dividend for the purposes of the "Enhanced Dividend Tax Credit System".

Conference Call

An investor presentation related to the Company's fourth quarter financial results is available at www.mapleleaffoods.com and can be found under Investor Material on the Investors page. A conference call will be held at 2:30 p.m. EDT on March 1, 2016, to review Maple Leaf Foods' fourth quarter financial results. To participate in the call, please dial 416-340-2216 or 866-223-7781. For those unable to participate, playback will be made available an hour after the event at 905-694-9451 or 800-408-3053 (Passcode: 5947801).

A webcast presentation of the fourth quarter financial results will also be available at:

http://edge.media-server.com/m/p/xn5f29sx

The Company's full financial statements and related Management's Discussion and Analysis are available on the Company's website.

Reconciliation of Non-IFRS Financial Measures

The Company uses the following non-IFRS measures: Adjusted Operating Earnings and Adjusted Earnings per Share. Management believes that these non-IFRS measures provide useful information to investors in measuring the financial performance of the Company for the reasons outlined below. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.

Adjusted Operating Earnings

Adjusted Operating Earnings, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as earnings before income taxes from continuing operations adjusted for items that are not considered representative of ongoing operational activities of the business and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. The table below provides a reconciliation of net earnings from continuing operations as reported under IFRS to Adjusted Operating Earnings for the three months ended, as indicated below, and a reconciliation of net earnings from continuing operations as reported under IFRS in the audited consolidated statements of net earnings to Adjusted Operating Earnings for the years then ended, as indicated below. Management believes that this basis is the most appropriate on which to evaluate operating results, as they are representative of the ongoing operations of the Company.


Three months ended December 31, 2015

($ thousands)
(Unaudited)

Meat
Products
Group

Agribusiness
Group

Non-allocated
costs

Consolidated

Net earnings from continuing operations








$

33,221

Income taxes








12,403

Earnings before income taxes from continuing operations








$

45,624

Interest expense and other financing costs








1,216

Other (income) expense


(144)


(162)


(5,604)


(5,910)

Restructuring and other related costs


(98)



12,409


12,311

Earnings (loss) from continuing operations


$

54,619


$

(6,862)


$

5,484


$

53,241

Decrease (increase) in fair value of biological assets(8)




(14,344)


(14,344)

Unrealized (gain) loss on futures contracts(8)




8,860


8,860

Adjusted Operating Earnings


$

54,619


$

(6,862)


$


$

47,757

 

 


Three months ended December 31, 2014

($ thousands)
(Unaudited)

Meat
Products
Group

Agribusiness
Group

Non-allocated
costs

Consolidated

Net loss from continuing operations








$

(22,992)

Income taxes








(8,489)

Loss before income taxes from continuing operations








$

(31,481)

Interest expense and other financing costs








957

Other (income) expense


3,477


(238)


5,365


8,604

Restructuring and other related costs


7,675



3,868


11,543

Earnings (loss) from continuing operations


$

(19,069)


$

5,390


$

3,302


$

(10,377)

Decrease (increase) in fair value of biological assets (8)




5,529


5,529

Unrealized (gains) loss on futures contracts (8)




(8,831)


(8,831)

Adjusted Operating Earnings(2)


$

(19,069)


$

5,390


$


$

(13,679)

 

 


Twelve months ended December 31, 2015

($ thousands)
(Audited)

Meat
Products 
Group

Agribusiness
Group

Non-allocated
costs

Consolidated

Net earnings from continuing operations








$

41,580

Income taxes








11,071

Earnings before income taxes from continuing operations








$

52,651

Interest expense and other financing costs








4,711

Other (income) expense


(884)


(275)


3,058


1,899

Restructuring and other related costs


15,321



18,504


33,825

Earnings (loss) from continuing operations


$

108,440


$

1,360


$

(16,714)


$

93,086

Decrease (increase) in fair value of biological assets(8)




12,778


12,778

Unrealized (gain) loss on futures contracts(8)




3,936


3,936

Adjusted Operating Earnings


$

108,440


$

1,360


$


$

109,800

 

 


Twelve months ended December 31, 2014

($ thousands)
(Audited)

Meat
Products
Group

Agribusiness
Group

Non-allocated
costs

Consolidated

Net loss from continuing operations








$

(213,813)

Income taxes








(74,556)

Loss before income taxes
from continuing operations








$

(288,369)

Interest expense and other financing costs








126,874

Change in the fair value of non-designated










interest rate swaps








(2,492)

Other (income) expense


4,462


(1,313)


13,642


16,791

Restructuring and other related costs


37,237



30,355


67,592

Earnings (loss) from continuing operations


$

(80,381)


$

8,642


$

(7,865)


$

(79,604)

Decrease (increase) in fair value of biological assets(8)




(530)


(530)

Unrealized (gain) loss on futures contracts(8)




(4,087)


(4,087)

Modification impact to long-term incentive plan(9)




8,734


8,734

Adjusted Operating Earnings(2)


$

(80,381)


$

8,642


$

(3,748)


$

(75,487)

 

Adjusted Earnings per Share

Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as basic earnings per share from continuing operations attributable to common shareholders, and is adjusted on the same basis as Adjusted Operating Earnings. The table below provides a reconciliation of basic earnings per share from continuing operations as reported under IFRS to Adjusted Earnings per Share for the three months ended, as indicated below, and a reconciliation of basic earnings per share from continuing operations as reported under IFRS in the audited consolidated statements of net earnings to Adjusted Earnings per Share for the years then ended, as indicated below. Management believes this basis is the most appropriate on which to evaluate financial results as they are representative of the ongoing operations of the Company.

 

($ per Share)

Three months ended
December 31,

Twelve months ended
December 31,

(Unaudited)

(Audited)

2015

2014(10)

2015

2014(10)

Basic earnings (loss) per share from continuing operations


$

0.24


$

(0.16)



$

0.30


$

(1.51)

Restructuring and other related costs(11)


0.07


0.06



0.18


0.36

Items included in other income not considered representative of











ongoing operations(12)


(0.03)


0.04



0.02


0.08

Change in the fair value of non-designated interest rate swaps(13)






(0.01)

Change in the fair value of unrealized (gains) losses on futures











contracts(13)


0.05


(0.04)



0.02


(0.02)

Change in the fair value of biological assets(13)


(0.08)


0.03



0.07


Other financing costs(14)






0.50

Modification impact to long-term incentive plan(9)






0.05

Adjusted Earnings per Share(15)


$

0.25


$

(0.08)



$

0.58


$

(0.56)

 

Forward-Looking Statements

This document contains, and the Company's oral and written public communications often contain, "forward-looking information" within the meaning of applicable securities law. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as beliefs and assumptions made by the Management of the Company. Such statements include, but are not limited to, statements with respect to objectives and goals, in addition to statements with respect to beliefs, plans, objectives, expectations, anticipations, estimates, and intentions. Specific forward-looking information in this document includes, but is not limited to, statements with respect to: the anticipated benefits, timing, actions, costs, and investments associated with the Value Creation Plan; expectations regarding the use of derivatives, futures and options; expectations regarding improving efficiencies; the expected use of cash balances; source of funds for ongoing business requirements; capital investments and expectations regarding capital expenditures; expectations regarding the implementation of environmental sustainability initiatives; expectations regarding the adoption of new accounting standards and the impact of such adoption on financial position; expectations regarding pension plan performance and future pension plan liabilities and contributions; expectations regarding levels of credit risk; and expectations regarding outcomes of legal actions. Words such as "expect", "anticipate", "intend", "may", "will", "plan", "believe", "seek", "estimate", and variations of such words and similar expressions are intended to identify such forward-looking information. These statements are not guarantees of future performance and involve assumptions and risks and uncertainties that are difficult to predict.  

In addition, these statements and expectations concerning the performance of the Company's business in general are based on a number of factors and assumptions including, but not limited to: the condition of the Canadian, U.S., and Japanese economies; the rate of exchange of the Canadian dollar to the U.S. dollar, and the Japanese yen; the availability and prices of raw materials, energy and supplies; product pricing; the availability of insurance; the competitive environment and related market conditions; improvement of operating efficiencies whether as a result of the Value Creation Plan or otherwise; continued access to capital; the cost of compliance with environmental and health standards; no adverse results from ongoing litigation; no unexpected actions of domestic and foreign governments; and the general assumption that none of the risks identified below or elsewhere in this document will materialize. All of these assumptions have been derived from information currently available to the Company, including information obtained by the Company from third-party sources. These assumptions may prove to be incorrect in whole or in part. In addition, actual results may differ materially from those expressed, implied, or forecasted in such forward-looking information, which reflect the Company's expectations only as of the date hereof. 

Factors that could cause actual results or outcomes to differ materially from the results expressed, implied, or forecasted by forward-looking information include, among other things:

  • risks associated with the Company focusing solely on the protein business;
  • risks related to the Company's decisions regarding any potential return of capital to shareholders;
  • risks associated with completing the Value Creation Plan and the risk associated with the concentration of production in fewer facilities;
  • risks associated with the availability of capital;
  • risks associated with changes in the Company's information systems and processes;
  • risks posed by food contamination, consumer liability, and product recalls;
  • risks associated with acquisitions, divestitures, and capital expansion projects;
  • impact on pension expense and funding requirements of fluctuations in the market prices of fixed income and equity securities and changes in interest rates;
  • cyclical nature of the cost and supply of hogs and the competitive nature of the pork market generally;
  • risks related to the health status of livestock;
  • impact of a pandemic on the Company's operations;
  • the Company's exposure to currency exchange risks;
  • ability of the Company to hedge against the effect of commodity price changes through the use of commodity futures and options;
  • impact of changes in the market value of the biological assets and hedging instruments;
  • impact of international events on commodity prices and the free flow of goods;
  • risks posed by compliance with extensive government regulation;
  • risks posed by litigation;
  • impact of changes in consumer tastes and buying patterns;
  • impact of extensive environmental regulation and potential environmental liabilities;
  • risks associated with a consolidating retail environment;
  • risks posed by competition;
  • risks associated with complying with differing employment laws and practices, the potential for work stoppages due to non-renewal of collective agreements, and recruiting and retaining qualified personnel;
  • risks associated with pricing the Company's products;
  • risks associated with managing the Company's supply chain; and
  • risks associated with failing to identify and manage the strategic risks facing the Company.

 

The Company cautions the reader that the foregoing list of factors is not exhaustive. These factors are discussed in more detail under the heading "Risk Factors"  in the Company's Annual Management's Discussion and Analysis for the period ended December 31, 2015, that is available on SEDAR at www.sedar.com. The reader should review such section in detail. Some of the forward-looking information may be considered to be financial outlooks for purposes of applicable securities legislation including, but not limited to, statements concerning future Adjusted EBITDA margins; capital expenditures; and cash costs. These financial outlooks are presented to allow the Company to benchmark the results of the Value Creation Plan. These financial outlooks may not be appropriate for other purposes and readers should not assume they will be achieved. The Company does not intend to, and the Company disclaims any obligation to, update any forward-looking information, whether written or oral, or whether as a result of new information, future events or otherwise, except as required by law. Additional information concerning the Company, including the Company's Annual Information Form, is available on SEDAR at www.sedar.com

Maple Leaf Foods Inc. is a leading Canadian consumer protein company, making high quality, innovative products under national brands including Maple Leaf®, Maple Leaf Prime®, Maple Leaf Natural Selections®, Schneiders®, Schneiders Country Naturals® and Mina™. The Company employs approximately 11,500 people across Canada and exports to global markets, including the U.S. and Asia. The Company is headquartered in Mississauga, Ontario and its shares trade on the Toronto Stock Exchange (MFI). 

 Footnote Legend

  1. Adjusted EBITDA is calculated as earnings from continuing operations before interest and income taxes plus depreciation and intangible asset amortization, adjusted for items that are not considered representative of ongoing operational activities of the business, and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred.  Please refer to the section entitled Non-IFRS Financial Measures in the Company's 2015 Management Discussion and Analysis
  2. 2014 figures exclude the results of the Bakery Products Group, which are reported as discontinued operations. Refer to Note 22 of the Company's 2015 audited consolidated financial statements. 
  3. Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as basic earnings per share from continuing operations attributable to common shareholders, and is adjusted on the same basis as Adjusted Operating Earnings. Please refer to the section entitled Reconciliation of Non-IFRS Financial Measures in this news release.
  4. Adjusted Operating Earnings, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as earnings from continuing operations adjusted for items that are not considered representative of ongoing operational activities of the business, and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Please refer to the section entitled Reconciliation of Non-IFRS Financial Measures in this news release.
  5. Unless otherwise stated, all per share amounts are presented as per basic share attributable to common shareholders.
  6. Free Cash Flow, a non-IFRS measure, is defined as cash flow from operations less additions to long-term assets.
  7. Non-allocated costs are comprised of expenses not separately identifiable to business segment groups, and do not form part of the measures used by the Company when assessing the segments' operating results.
  8. Regarding biological assets, please refer to Note 7 of the Company's 2015 annual audited consolidated financial statements. Unrealized gains/losses on futures contracts are reported within cost of sales and selling, general and administrative expenses respectively in the Company's 2015 annual audited consolidated financial statements.
  9. Relates to an $8.7 million modification of long-term incentive compensation plan as a result of the costs being fixed and payments accelerated, which was a decision made conditional on the sale of Canada Bread, and is therefore not considered representative of ongoing operational activities of the business, net of tax.
  10. 2014 figures reflect the reclassification of the change in fair value of non-designated interest rate swaps to other income. Refer to Note 19 of the Company's 2015 audited consolidated financial statements.
  11. Includes per share impact of restructuring and other related costs, net of tax.
  12. Primarily includes a depreciation charge on assets servicing divested businesses, interest income and gains/losses associated with investment properties and assets held for sale, net of tax.  
  13. Includes per share impact of the change in fair value of non-designated interest rate swaps, unrealized (gains) losses on futures contracts and the change in fair value of biological assets, net of tax.
  14. Includes a $76.3 million early repayment premium to lenders, $8.9 million write-off of deferred financing fees, $3.8 million of financing fees associated with the new credit facility, and a $9.6 million loss transferred from accumulated other comprehensive income (loss) into earnings due to the settlement of interest rate swaps that are no longer designated as hedging instruments, net of tax.  
  15. May not add due to rounding.

 

Consolidated Balance Sheets

(In thousands of Canadian dollars)
(Audited)

As at December 31,
2015


As at December 31,
2014



ASSETS




Current assets





Cash and cash equivalents

$

292,269


$

496,328


Accounts receivable

57,958


60,396


Notes receivable

103,706


110,209


Inventories

257,671


270,401


Biological assets

103,877


105,743


Prepaid expenses and other assets

14,946


20,157


Assets held for sale

130


1,107


$

830,557


$

1,064,341


Property and equipment

1,082,360


1,042,506


Investment property

7,336


3,312


Employee benefits

66,519


88,162


Other long-term assets

10,791


9,881


Deferred tax asset

66,911


74,986


Goodwill

428,236


428,236


Intangible assets

138,155


165,066


Total assets

$

2,630,865


$

2,876,490



LIABILITIES AND EQUITY


Current liabilities



Accounts payable and accruals

$

256,473


$

275,249


Provisions

32,531


60,443


Current portion of long-term debt

813


472


Income taxes payable

9,670


26,614


Other current liabilities

29,637


24,383


$

329,124


$

387,161


Long-term debt

9,843


10,017


Employee benefits

203,241


196,482


Provisions

14,622


17,435


Other long-term liabilities

20,901


20,899


Total liabilities

$

577,731


$

631,994



Shareholders' equity


Share capital

$

882,770


$

936,479

Retained earnings

1,172,864


1,228,815

Contributed surplus


79,652

Accumulated other comprehensive income (loss) associated





with continuing operations

(414)


(226)

Treasury stock

(2,086)


(224)

Total shareholders' equity

$

2,053,134


$

2,244,496

Total liabilities and equity

$

2,630,865


$

2,876,490

 

Consolidated Statements of Net Earnings (Loss)


Three months ended
December 31,

Twelve months ended
December 31,

(In thousands of Canadian dollars, except share amounts)

2015

2014

2015

2014


(Unaudited)

(Unaudited)

(Audited)

(Audited)

Sales

$

873,123

$

794,007

$

3,292,932

$

3,157,241

Cost of goods sold

756,277

743,114

2,911,791

2,938,964

Gross margin

$

116,846

$

50,893

$

381,141

$

218,277

Selling, general and administrative expenses

63,605

61,270

288,055

297,881

Earnings (loss) from continuing operations before the following:

$

53,241

$

(10,377)

$

93,086

$

(79,604)

Restructuring and other related costs

(12,311)

(11,543)

(33,825)

(67,592)

Change in fair value of non-designated interest rate swaps

2,492

Other income (expense)

5,974

(8,604)

(1,899)

(16,791)

Earnings (loss) before interest and income taxes from continuing operations

$

46,904

$

(30,524)

$

57,362

$

(161,495)

Interest expense and other financing costs

1,216

957

4,711

126,874

Earnings (loss) before income taxes from continuing operations

$

45,688

$

(31,481)

$

52,651

$

(288,369)

Income taxes expense (recovery)

12,403

(8,489)

11,071

(74,556)

Earnings (loss) from continuing operations

$

33,285

$

(22,992)

$

41,580

$

(213,813)

Earnings (loss) from discontinued operations

(5,196)

925,719

Net earnings (loss)

$

33,285

$

(28,188)

$

41,580

$

711,906

Attributed to:




Common shareholders

$

33,285

$

(28,188)

$

41,580

$

709,931

Non-controlling interest

1,975


$

33,285

$

(28,188)

$

41,580

$

711,906

Earnings (loss) per share attributable to common shareholders:






Basic earnings (loss) per share

$

0.24

$

(0.20)

$

0.30

$

5.03


Diluted earnings (loss) per share

$

0.24

$

(0.20)

$

0.29

$

5.03


Basic earnings (loss) per share from continuing operations

$

0.24

$

(0.16)

$

0.30

$

(1.51)


Diluted earnings (loss) per share from continuing operations

$

0.24

$

(0.16)

$

0.29

$

(1.51)

 

Weighted average number of shares (millions)





Basic

136.7

141.7

140.2

141.2


Diluted

138.2

141.7

141.7

141.2

 

Consolidated Statements of Other Comprehensive Income (Loss)


Three months ended
December 31,

Twelve months ended
December 31,

(In thousands of Canadian dollars)

2015

2014

2015

2014


(Unaudited)

(Unaudited)

(Audited)

(Audited)

Net earnings (loss)

$

33,285

$

(28,188)

$

41,580

$

711,906

Other comprehensive income (loss)





Actuarial gains and losses that will not be reclassified to profit or loss

(Net of tax of $4.7 million and $0.2 million; 2014: $14.4 million and $17.0 million)

$

(13,603)

$

(43,595)

$

389

$

(50,869)

Items that are or may be reclassified subsequently to profit or loss:






Change in accumulated foreign currency translation adjustment

(Net of tax of $0.0 million)

$

550

$

(305)

$

1,769

$

(557)


Change in unrealized gains and losses on cash flow hedges

(Net of tax of $0.6 million and $0.7 million; 2014: $0.0 million and $1.5 million)

1,792

(62)

(1,957)

4,125

Total items that are or may be reclassified subsequently to profit or loss

$

2,342

$

(367)

$

(188)

$

3,568

Other comprehensive income (loss) from continuing operations

$

(11,261)

$

(43,962)

$

201

$

(47,301)


Other comprehensive income (loss) from discontinued operations(i)
(Net of tax of $0.0 million and $0.0 million; 2014: $0.0 million and $1.3 million)

(569)

Total other comprehensive income (loss)

$

(11,261)

$

(43,962)

$

201

$

(47,870)

Comprehensive income (loss)

$

22,024

$

(72,150)

$

41,781

$

664,036

Attributed to:





Common shareholders

$

22,024

$

(72,150)

$

41,781

$

662,305

Non-controlling interest

$

$

$

$

1,731

 (i)

The above amount includes a loss of $3.6 million, net of tax of $1.2 million for the year ended December 31, 2014 relating to actuarial gains and losses that will not subsequently be re-classified to profit or loss.

 

Consolidated Statements of Changes in Total Equity


Attributable to Common Shareholders


(In thousands of Canadian dollars)
(Audited)

Share
capital

Retained
earnings

Contributed
surplus

Total
accumulated
other
comprehensive
income (loss)
associated with
continuing
operations

Total
accumulated
other
comprehensive
income (loss)
associated with
assets
held for sale

Treasury
stock

Non-
controlling
interest

Total
equity

Balance at December 31, 2014

$

936,479

$

1,228,815

$

79,652

$

(226)

$

$

(224)

$

$

2,244,496


Net earnings

41,580

41,580


Other comprehensive income (loss)

389

(188)

201


Dividends declared ($0.32 per share)

(44,668)

(44,668)


Share-based compensation expense

12,870

12,870


Obligation for repurchase of shares

(3,367)

(9,207)

(12,574)


Repurchase of shares

(53,377)

(38,956)

(90,216)

(182,549)


Issuance of treasury stock

(3,860)

(2,306)

3,326

(2,840)


Exercise of stock options

3,035

3,035


Cash settlement of share based payment

(1,229)

(1,229)


Shares purchased by RSU trust

(5,188)

(5,188)

Balance at December 31, 2015

$

882,770

$

1,172,864

$

$

(414)

$

$

(2,086)

$

$

2,053,134



Attributable to Common Shareholders


(In thousands of Canadian dollars)
(Audited)

Share
capital

Retained
earnings

Contributed
surplus

Total
accumulated
other
comprehensive
income (loss)
associated with
continuing
operations

Total
accumulated
other
comprehensive
income (loss)
associated with
assets
held for sale

Treasury
stock

Non-
controlling
interest

Total
equity

Balance at December 31, 2013

$

905,216

$

602,717

$

79,139

$

(4,593)

$

$

(1,350)

$

60,863

$

1,641,992


Net earnings

709,931


1,975

711,906


Reclassification to assets held for sale

799

(799)


Other comprehensive income (loss)

(54,083)

3,568

2,889

(244)

(47,870)


Dividends declared ($0.16 per share)

(22,656)

(3,017)

(25,673)


Share-based compensation expense

27,501

27,501


Disposal of business

(2,090)

(59,577)

(61,667)


Issuance of treasury stock

(1,150)

(10,976)

12,126


Exercise of stock options

31,263

31,263


Shares purchased by RSU trust

(11,000)

(11,000)


Modification of share-based compensation plan

(5,944)

(16,012)

(21,956)

Balance at December 31, 2014

$

936,479

$

1,228,815

$

79,652

$

(226)

$

$

(224)

$

$

2,244,496

 

Consolidated Statements of Cash Flows


Three months ended
December 31,

Twelve months ended
December 31,

(In thousands of Canadian dollars)

2015

2014

2015

2014

CASH PROVIDED BY (USED IN):

(Unaudited)

(Unaudited)

(Audited)

(Audited)

Operating activities




Net earnings (loss)

$

33,285

$

(28,188)

$

41,580

$

711,906


Add (deduct) items not affecting cash:







Change in fair value of biological assets

(14,344)

5,529

12,778

(530)



Depreciation and amortization

28,529

31,306

123,480

111,375



Share-based compensation

6,198

1,384

12,870

27,501



Deferred income taxes

11,462

(57,820)

9,178

(26,533)



Income tax current

941

48,031

1,893

59,100



Interest expense and other financing costs

1,216

957

4,711

127,660



Loss (gain) on sale of long-term assets

(4,163)

634

(10,344)

(718)



Loss (gain) on sale of business

6,497

(1,000,968)



Change in fair value of non-designated derivative financial instruments

7,727

(8,914)

(1,429)

(10,983)



Impairment of assets (net of reversals)

792

1,907

2,466


Change in net pension liability

6,770

6,148

26,761

18,794


Net income taxes paid

(605)

7,285

(12,735)

(1,442)


Net settlement of financial instruments

(23,631)


Early repayment premium

(76,311)


Interest paid

(1,022)

(861)

(3,674)

(39,897)


Change in provision for restructuring and other related costs

6,011

(860)

(14,963)

30,409


Settlement of cash-settled restricted share units

(5,904)

(21,640)

(11,236)

(21,640)


Other

(2,796)

27,069

2,519

(5,741)


Change in non-cash operating working capital

4,048

(1,784)

(23,889)

(243,035)

Cash provided by (used in) operating activities

$

77,353

$

15,565

$

159,407

$

(362,218)

Financing activities






Dividends paid

$

(10,842)

$

(5,705)

$

(44,668)

$

(22,656)


Dividends paid to non-controlling interest

(24,621)


Net increase (decrease) in long-term debt

(83)

250

(125)

(698,889)


Net drawings (payments) on the credit facility

(255,000)


Exercise of stock options

847

9,467

3,035

31,263


Repurchase of shares

(44,194)

(182,549)


Payment of financing fees

(277)

(3,769)

Cash provided by (used in) financing activities

$

(54,272)

$

4,012

$

(224,584)

$

(973,672)

Investing activities






Additions to long-term assets

$

(38,204)

$

(35,235)

$

(147,699)

$

(259,181)


Capitalization of interest expense

(5,504)


Adjustment to sale of business

(468)


Proceeds from sale of business

1,647,015


Transaction costs

(1)

785

(64)

(28,227)


Cash associated with divested business

(23,011)


Proceeds from sale of long-term assets

4,854

963

14,069

10,332


Purchase of treasury stock

(4,000)

(5,188)

(11,000)

Cash provided by (used in) investing activities

$

(37,351)

$

(33,487)

$

(138,882)

$

1,329,956

Increase (decrease) in cash and cash equivalents

$

(14,270)

$

(13,910)

$

(204,059)

$

(5,934)

Net cash and cash equivalents, beginning of period

306,539

510,238

496,328

502,262

Net cash and cash equivalents, end of period

$

292,269

$

496,328

$

292,269

$

496,328

 

Segmented Financial Information


Three months ended December 31,

Twelve months ended December 31,

(In thousands of Canadian dollars)

2015

2014

2015

2014


(Unaudited)

(Unaudited)

(Audited)

(Audited)

Sales






Meat Products Group

$

868,542

$

789,725

$

3,276,994

$

3,135,376


Agribusiness Group

4,581

4,282

15,938

21,865


Bakery Products Group(i)

567,861

Total sales

$

873,123

$

794,007

$

3,292,932

$

3,725,102

Sales from discontinued operations

(567,861)

Sales from continuing operations

$

873,123

$

794,007

$

3,292,932

$

3,157,241

Earnings (loss) before restructuring and other related costs and other income






Meat Products Group

$

54,619

$

(19,069)

$

108,440

$

(80,381)


Agribusiness Group

(6,862)

5,390

1,360

8,642


Bakery Products Group(i)

47,829


Non-allocated costs

5,484

3,302

(16,714)

(7,865)

Total earnings (loss) before restructuring and other related costs and other income

$

53,241

$

(10,377)

$

93,086

$

(31,775)

Earnings (loss) before restructuring and other related costs and other income from discontinued operations

(47,829)

Earnings (loss) before restructuring and other related costs and other income from continuing operations

$

53,241

$

(10,377)

$

93,086

$

(79,604)

Capital expenditures






Meat Products Group

$

29,838

$

27,470

$

123,455

$

206,958


Agribusiness Group

7,367

4,281

22,295

9,063


Bakery Products Group(i)

17,789


$

37,205

$

31,751

$

145,750

$

233,810

Depreciation and amortization






Meat Products Group

$

25,870

$

25,066

$

102,302

$

86,027


Agribusiness Group

1,819

1,811

6,588

5,928


Non-allocated costs(ii)

840

4,429

14,590

14,278


Bakery Products Group(i)

5,142


$

28,529

$

31,306

$

123,480

$

111,375

(i)

The prior year results of Canada Bread were included in the comparative results of the Bakery Products Group.

(ii)

Includes depreciation on assets used to service divested business.

 

(In thousands of Canadian dollars)

As at December 31,

(Audited)

2015

2014

Total assets




Meat Products Group

$

1,853,146

$

1,965,280


Agribusiness Group

188,890

211,516


Non-allocated assets

588,829

699,694


$

2,630,865

$

2,876,490

Goodwill




Meat Products Group

$

428,236

$

428,236

 

SOURCE Maple Leaf Foods Inc.



For further information: Investor Contact: Nick Boland, VP Investor Relations: 905-285-5898; Media Contact: 888-995-5030

RELATED LINKS
http://www.mapleleaffoods.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890